Suchergebnisse - "Riaz, Irbaz B"

PubPharm (31)

1

Integrating large language models in systematic reviews : a framework and case study using ROBINS-I for risk of bias assessment

enthalten in: BMJ evidence-based medicine | 2024

von Hasan, B. | Saadi, S. | Rajjoub, N. | +8

2

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

enthalten in: European urology oncology | 2023

von Orme, J. | Taza, F. | De Sarkar, N. | +34

3

Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach

enthalten in: Cancers | 2023

von Sarkar, S. | Min, K. | Ikram, W. | +10

4

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2022

von Velez, M. | Kosiorek, H. | Egan, J. | +10

5

Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials

enthalten in: The American journal of medicine | 2022

von Riaz, I. | Islam, M. | Khan, A. | +13

6

Safety of proprotein convertase subtilisin/kexin 9 inhibitors : a systematic review and meta-analysis

enthalten in: Heart (British Cardiac Society) | 2022

von Li, J. | Du, H. | Wang, Y. | +14

CommentIn: Heart. 2022 Jul 27;108(16):1250-1252. - PMID 35508402

7

Assessment of Electronic Health Record for Cancer Research and Patient Care Through a Scoping Review of Cancer Natural Language Processing

enthalten in: JCO clinical cancer informatics | 2022

von Wang, L. | Fu, S. | Wen, A. | +11

8

Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics : A meta-analysis of randomized controlled trials

enthalten in: Cancer | 2022

von Chakraborty, R. | Siddiqi, R. | Willson, G. | +8

9

Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE) : a double-blind, randomised, phase 2 trial

enthalten in: The Lancet. Oncology | 2022

von Hussain, S. | Lester, J. | Jackson, R. | +17

CommentIn: Eur Urol. 2023 Oct;84(4):440-441. - PMID 37302943

10

Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma

enthalten in: The oncologist | 2022

von Ravi, P. | Ravi, A. | Riaz, I. | +10